Interventional Oncology Devices | Market Analysis | Europe | 2019
The European interventional oncology device market will be driven by moderate procedure volume growth, spurred by enhanced cancer detection, rising patient and physician awareness, improved reimbursement, and increased physician training on interventional oncology procedures. This market will continue to be characterized by rapid cannibalization of RF ablation by microwave ablation, new emerging technologies, and strong competition between embolization particle treatments.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for interventional oncology devices in Europe across a 10-year period.